Indeed, adropin is involved in downregulation of the mRNA expression of several endothelial cell markers, such as leukocyte differentiation antigen 31 and vascular endothelial cadherin, which play a pivotal role in endothelial dysfunction and plaque instability [68]. This evidence concerns the gene ENHO and endothelial dysfunction.